Targeting miR-31 represses tumourigenesis and dedifferentiation of BRAF V600E -associated thyroid carcinoma.
Peitao ZhangLizhao GuanWei SunYu ZhangYa-Ying DuShukai YuanXiaolong CaoZhengquan YuQiang JiaXiangqian ZhengZhaowei MengXingrui LiLi ZhaoPublished in: Clinical and translational medicine (2024)
-associated DTC tumourigenesis and dedifferentiation, also highlight a potential adjuvant therapeutic strategy for advanced DTC.